Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
NCT00525005
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Stomach Neoplasms
Interventions
DRUG:
DOS (Docetaxel, Oxaliplatin and S-1)
Sponsor
Hallym University Medical Center
Collaborators
[object Object]
[object Object]